Pipeline Assessment

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Assessment of pipeline activities around client’s area of interest to support strategic decisions

Problem Statement:

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products for cancer treatment. They wished to identify currently active T-Cell Receptor (TCR) products in research and development for cancer treatment.

Our Methodology:
  • Detailed Assessment of pipeline activity of T-Cell Receptor (TCR) products
  • Clinical Trial Assessment of Clinical Stage products of T-Cell Receptor (TCR) arena
  • Company Assessment via Funding/Collaboration/Partnership Analysis
  • Analyst Comments on R&D developments
Results:
  • Detailed pipeline profiles of T-Cell Receptor (TCR) products
  • Additional comments on Inactive (Discontinued and Dormant) products.
  • Therapeutic assessment of active pipeline products
  • Detailed profiles of Companies with key coverage of collaboration/partnering activities

Related Insights

Launch Landscape Analysis
Launch Landscape Analysis

A mid pharma client based in Germany, involved in late-stage development of a therapy for PID, with effective marketing [...]

View Case
Mergers and Acquisitions
Mergers and Acquisitions

A large medical device client, based in the United States with capabilities in drug delivery medical devices, [...]

View Case
R&D Landscape Assessment, Manufacturing & Commercial Capabilities
R&D Landscape Assessment, Manufacturing & Commercial Capabilities

A large pharma client was working to develop their API and FD, and was interested to assess CDMO companies and their capabilities in this domain to provide benchmarking of the best company for outsourcing their project. [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.